Starling Oncology, Inc. Common Stock · as of 2026-03-31
| Fund | Ticker | Position value | % of fund | Balance | Fund net assets | Match |
|---|---|---|---|---|---|---|
| PROFUND VP SMALL CAP ProFunds | — | $620.14 | 0.01% | 202 NS | $11.88M | FIGI |
| Russell 2000 Fund Rydex Series Funds | — | $420.59 | 0.00% | 137 NS | $12.87M | FIGI |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | RESM | $297.79 | 0.01% | 97 NS | $3.06M | FIGI |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | — | $254.81 | 0.00% | 83 NS | $5.96M | FIGI |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | — | $49.12 | 0.00% | 16 NS | $2.76M | FIGI |